Maximilian Diehn
#139,475
Most Influential Person Now
Researcher
Maximilian Diehn's AcademicInfluence.com Rankings
Maximilian Diehncomputer-science Degrees
Computer Science
#6602
World Rank
#6960
Historical Rank
Informatics
#40
World Rank
#41
Historical Rank
Maximilian Diehnphilosophy Degrees
Philosophy
#7218
World Rank
#10399
Historical Rank
Logic
#4282
World Rank
#5553
Historical Rank
Download Badge
Computer Science Philosophy
Maximilian Diehn's Degrees
- PhD Biomedical Informatics Stanford University
- Doctorate Medicine Stanford University
Why Is Maximilian Diehn Influential?
(Suggest an Edit or Addition)Maximilian Diehn's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Robust enumeration of cell subsets from tissue expression profiles (2015) (6229)
- Association of reactive oxygen species levels and radioresistance in cancer stem cells (2009) (2233)
- The prognostic landscape of genes and infiltrating immune cells across human cancers (2015) (2055)
- An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage (2013) (1670)
- Determining cell-type abundance and expression from bulk tissues with digital cytometry (2019) (1505)
- Downregulation of miRNA-200c Links Breast Cancer Stem Cells with Normal Stem Cells (2009) (1216)
- Individuality and variation in gene expression patterns in human blood (2003) (822)
- Integrated digital error suppression for improved detection of circulating tumor DNA (2016) (738)
- Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells (2009) (612)
- Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling. (2017) (526)
- Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients (2016) (509)
- Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme. (2005) (508)
- Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer (2020) (494)
- SOURCE: a unified genomic resource of functional annotations, ontologies, and gene expression data (2003) (466)
- Stereotyped and specific gene expression programs in human innate immune responses to bacteria (2002) (447)
- Identification of noninvasive imaging surrogates for brain tumor gene-expression modules (2008) (428)
- Genomic expression programs and the integration of the CD28 costimulatory signal in T cell activation (2002) (372)
- Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review. (2018) (367)
- Evolution and clinical impact of co-occurring genetic alterations in advanced-stage EGFR-mutant lung cancers (2017) (357)
- Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review. (2018) (355)
- Gene expression patterns in ovarian carcinomas. (2003) (333)
- Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non–Small Cell Lung Cancer (2017) (326)
- Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA (2016) (313)
- Biochemical Interactions Integrating Itk with the T Cell Receptor-initiated Signaling Cascade* (2000) (304)
- Isolation and Molecular Characterization of Cancer Stem Cells in MMTV‐Wnt‐1 Murine Breast Tumors (2008) (302)
- Cell-type specific gene expression profiles of leukocytes in human peripheral blood (2006) (301)
- Integrating genomic features for non-invasive early lung cancer detection (2020) (257)
- Cancer stem cells and radiotherapy: new insights into tumor radioresistance. (2006) (243)
- Transformation of follicular lymphoma to diffuse large-cell lymphoma: Alternative patterns with increased or decreased expression of c-myc and its regulated genes (2002) (241)
- Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing. (2015) (235)
- Circulating Tumor DNA Measurements As Early Outcome Predictors in Diffuse Large B-Cell Lymphoma. (2018) (235)
- Transcriptional programs activated by exposure of human prostate cancer cells to androgen (2002) (203)
- Role of KEAP1/NRF2 and TP53 Mutations in Lung Squamous Cell Carcinoma Development and Radiation Resistance. (2017) (201)
- Degradation of proteins from the ER of S. cerevisiae requires an intact unfolded protein response pathway. (2000) (198)
- FACTERA: a practical method for the discovery of genomic rearrangements at breakpoint resolution (2014) (183)
- In vivo regulation of human skeletal muscle gene expression by thyroid hormone. (2002) (165)
- Predicting HLA class II antigen presentation through integrated deep learning (2019) (163)
- Large-scale identification of secreted and membrane-associated gene products using DNA microarrays (1999) (162)
- ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal–Anal Task Forces whitepaper (2020) (153)
- Noninvasive Early Identification of Therapeutic Benefit from Immune Checkpoint Inhibition (2020) (151)
- Therapeutic implications of the cancer stem cell hypothesis. (2009) (141)
- Early-Stage Non-Small Cell Lung Cancer: Quantitative Imaging Characteristics of (18)F Fluorodeoxyglucose PET/CT Allow Prediction of Distant Metastasis. (2016) (137)
- Stereotactic ablative radiotherapy (SABR) for treatment of central and ultra-central lung tumors. (2015) (128)
- Reprogramming the immunological microenvironment through radiation and targeting Axl (2016) (127)
- Stereotactic ablative radiotherapy should be combined with a hypoxic cell radiosensitizer. (2010) (126)
- Illuminating radiogenomic characteristics of glioblastoma multiforme through integration of MR imaging, messenger RNA expression, and DNA copy number variation. (2013) (125)
- Circulating tumor DNA dynamics predict benefit from consolidation immunotherapy in locally advanced non-small-cell lung cancer (2020) (124)
- Current Status and Future Perspectives on Neoadjuvant Therapy in Lung Cancer (2018) (109)
- T Cell Receptor-Independent Basal Signaling via Erk and Abl Kinases Suppresses RAG Gene Expression (2003) (108)
- Detection and Surveillance of Bladder Cancer Using Urine Tumor DNA. (2019) (107)
- Corrigendum: Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients (2016) (106)
- Circulating tumor DNA analysis for detection of minimal residual disease after chemoradiotherapy for localized esophageal cancer. (2019) (104)
- Targeting Unique Metabolic Properties of Breast Tumor Initiating Cells (2014) (96)
- Molecular profiling of single circulating tumor cells from lung cancer patients (2016) (94)
- Neurotrophic factor GDNF promotes survival of salivary stem cells. (2014) (90)
- Genome-Scale Identification of Membrane-Associated Human mRNAs (2006) (90)
- Predicting Radiotherapy Responses and Treatment Outcomes Through Analysis of Circulating Tumor DNA. (2015) (86)
- Large-scale identification of secreted and membrane-associated gene products using DNA microarrays (1999) (85)
- A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE) (2017) (84)
- Pulmonary ventilation imaging based on 4-dimensional computed tomography: comparison with pulmonary function tests and SPECT ventilation images. (2014) (82)
- Stereotactic Ablative Radiotherapy for Reirradiation of Locally Recurrent Lung Tumors (2012) (79)
- Transcriptional response of human mast cells stimulated via the FcεRI and identification of mast cells as a source of IL-11 (2002) (79)
- A population-based comparative effectiveness study of radiation therapy techniques in stage III non-small cell lung cancer. (2014) (77)
- A mathematical model of ctDNA shedding predicts tumor detection size (2020) (76)
- Potential clinical utility of ultrasensitive circulating tumor DNA detection with CAPP-Seq (2015) (72)
- Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA (2021) (72)
- ERBB2‐Mutated Metastatic Non–Small Cell Lung Cancer: Response and Resistance to Targeted Therapies (2017) (72)
- Tumor volume-adapted dosing in stereotactic ablative radiotherapy of lung tumors. (2010) (71)
- Differential gene expression in anatomical compartments of the human eye (2005) (69)
- Robust Intratumor Partitioning to Identify High-Risk Subregions in Lung Cancer: A Pilot Study. (2016) (65)
- Comparing functional genomic datasets: lessons from DNA microarray analyses of host-pathogen interactions. (2001) (63)
- Control of inflammation by stromal Hedgehog pathway activation restrains colitis (2016) (62)
- Erythropoietin promotes breast tumorigenesis through tumor-initiating cell self-renewal. (2014) (61)
- 4D CT lung ventilation images are affected by the 4D CT sorting method. (2013) (57)
- The Future of Radiobiology. (2018) (57)
- Presynaptic homeostasis at CNS nerve terminals compensates for lack of a key Ca2+ entry pathway. (2004) (57)
- Precision Hypofractionated Radiation Therapy in Poor Performing Patients With Non-Small Cell Lung Cancer: Phase 1 Dose Escalation Trial. (2015) (56)
- Normal Tissue Constraints for Abdominal and Thoracic Stereotactic Body Radiotherapy. (2017) (56)
- ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group. (2022) (55)
- Inhibition of Mouse Breast Tumor-Initiating Cells by Calcitriol and Dietary Vitamin D (2015) (55)
- Galectin-1 Mediates Radiation-Related Lymphopenia and Attenuates NSCLC Radiation Response (2014) (54)
- High-throughput sequencing for noninvasive disease detection in hematologic malignancies. (2017) (54)
- Type I collagen is overexpressed in medulloblastoma as a component of tumor microenvironment (2007) (53)
- KEAP1/NFE2L2 mutations predict lung cancer radiation resistance that can be targeted by glutaminase inhibition. (2020) (53)
- Colorectal Histology Is Associated With an Increased Risk of Local Failure in Lung Metastases Treated With Stereotactic Ablative Radiation Therapy. (2015) (52)
- Role of KEAP1/NFE2L2 Mutations in the Chemotherapeutic Response of Patients with Non–Small Cell Lung Cancer (2019) (52)
- Deep segmentation networks predict survival of non-small cell lung cancer (2019) (52)
- GFPT2-Expressing Cancer-Associated Fibroblasts Mediate Metabolic Reprogramming in Human Lung Adenocarcinoma. (2018) (52)
- Durvalumab for Stage III EGFR-Mutated Non-Small Cell Lung Cancer After Definitive Chemoradiotherapy. (2021) (51)
- Endothelial deletion of Ino80 disrupts coronary angiogenesis and causes congenital heart disease (2018) (51)
- Circulating Tumor DNA Analysis to Assess Risk of Progression after Long-term Response to PD-(L)1 Blockade in NSCLC (2020) (51)
- Integrating Tumor and Stromal Gene Expression Signatures With Clinical Indices for Survival Stratification of Early-Stage Non-Small Cell Lung Cancer. (2015) (51)
- Lack of supporting data make the risks of a clinical trial of radiation therapy as a treatment for COVID-19 pneumonia unacceptable☆ (2020) (49)
- Liquid Biopsy for Advanced Non-Small Cell Lung Cancer: A Consensus Statement from The International Association for the Study of Lung Cancer (IASLC). (2019) (48)
- The landscape of tumor cell states and ecosystems in diffuse large B cell lymphoma. (2021) (48)
- Atlas of clinically distinct cell states and ecosystems across human solid tumors (2021) (48)
- Metabolic imaging metrics correlate with survival in early stage lung cancer treated with stereotactic ablative radiotherapy. (2012) (46)
- American Society of Clinical Oncology Road to Recovery Report: Learning From the COVID-19 Experience to Improve Clinical Research and Cancer Care. (2020) (46)
- Global analysis of shared T cell specificities in human non-small cell lung cancer enables HLA inference and antigen discovery (2021) (44)
- Detecting Liquid Remnants of Solid Tumors: Circulating Tumor DNA Minimal Residual Disease. (2021) (43)
- Combination Approach for Detecting Different Types of Alterations in Circulating Tumor DNA in Leiomyosarcoma (2018) (41)
- Single cell analysis reveals distinct immune landscapes in transplant and primary sarcomas that determine response or resistance to immunotherapy (2020) (39)
- High retention and safety of percutaneously implanted endovascular embolization coils as fiducial markers for image-guided stereotactic ablative radiotherapy of pulmonary tumors. (2010) (39)
- Clinical implementation of intrafraction cone beam computed tomography imaging during lung tumor stereotactic ablative radiation therapy. (2013) (37)
- Neuregulin autocrine signaling promotes self-renewal of breast tumor-initiating cells by triggering HER2/HER3 activation. (2014) (35)
- Examining the living genome in health and disease with DNA microarrays. (2000) (32)
- Genetic determinants of EGFR-Driven Lung Cancer Growth and Therapeutic Response In Vivo (2020) (32)
- Radiological tumor classification across imaging modality and histology (2021) (31)
- Reducing 4D CT artifacts using optimized sorting based on anatomic similarity. (2011) (31)
- Intrafraction verification of gated RapidArc by using beam-level kilovoltage X-ray images. (2012) (30)
- Case series of MET exon 14 skipping mutation-positive non-small-cell lung cancers with response to crizotinib and cabozantinib (2019) (30)
- Tumor Volume as a Potential Imaging-Based Risk-Stratification Factor in Trimodality Therapy for Locally Advanced Non-small Cell Lung Cancer (2011) (29)
- Impact of KEAP1/NFE2L2/CUL3 mutations on duration of response to EGFR tyrosine kinase inhibitors in EGFR mutated non-small cell lung cancer. (2019) (28)
- Dosimetric Factors and Toxicity in Highly Conformal Thoracic Reirradiation. (2016) (27)
- Inferring gene expression from cell-free DNA fragmentation profiles (2022) (27)
- Data normalization considerations for digital tumor dissection (2017) (27)
- Pre-treatment non-target lung FDG-PET uptake predicts symptomatic radiation pneumonitis following Stereotactic Ablative Radiotherapy (SABR). (2016) (25)
- A 3-D Riesz-Covariance Texture Model for Prediction of Nodule Recurrence in Lung CT (2016) (24)
- Mid-radiotherapy PET/CT for prognostication and detection of early progression in patients with stage III non-small cell lung cancer. (2017) (24)
- Imaging features associated with disease progression after stereotactic ablative radiotherapy for stage I non-small-cell lung cancer. (2014) (24)
- Capturing Genomic Evolution of Lung Cancers through Liquid Biopsy for Circulating Tumor DNA (2017) (23)
- Functional significance of U2AF1 S34F mutations in lung adenocarcinomas (2019) (23)
- Metastatic cancer stem cells: an opportunity for improving cancer treatment? (2010) (23)
- Circulating tumor DNA testing in advanced non-small cell lung cancer. (2018) (22)
- Deactivated CRISPR Associated Protein 9 for Minor-Allele Enrichment in Cell-Free DNA. (2018) (22)
- Early response evaluation using primary tumor and nodal imaging features to predict progression-free survival of locally advanced non-small cell lung cancer (2020) (22)
- A human lung tumor microenvironment interactome identifies clinically relevant cell-type cross-talk (2020) (22)
- Migration of implanted markers for image‐guided lung tumor stereotactic ablative radiotherapy (2013) (22)
- Long-Term Outcomes and Genetic Predictors of Response to Metastasis-Directed Therapy Versus Observation in Oligometastatic Prostate Cancer: Analysis of STOMP and ORIOLE Trials (2022) (21)
- A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE) (2017) (21)
- The Myc Connection: ES Cells and Cancer (2010) (21)
- Clinical impact of dose overestimation by effective path length calculation in stereotactic ablative radiation therapy of lung tumors. (2013) (20)
- Identification and genetic manipulation of human and mouse oesophageal stem cells (2015) (20)
- Prognostic Value of Pretreatment FDG‐PET Parameters in High‐dose Image‐guided Radiotherapy for Oligometastatic Non–Small‐cell Lung Cancer (2018) (20)
- Early prediction of clinical outcomes in resected stage II and III colorectal cancer (CRC) through deep sequencing of circulating tumor DNA (ctDNA). (2017) (19)
- Randomized Phase II Study of Preoperative Chemoradiotherapy ± Panitumumab Followed by Consolidation Chemotherapy in Potentially Operable Locally Advanced (Stage IIIa, N2+) Non–Small Cell Lung Cancer: NRG Oncology RTOG 0839 (2017) (19)
- To SABR or not to SABR? Indications and contraindications for stereotactic ablative radiotherapy in the treatment of early-stage, oligometastatic, or oligoprogressive non-small cell lung cancer. (2015) (19)
- 18F-EF5 PET-based Imageable Hypoxia Predicts Local Recurrence in Tumors Treated With Highly Conformal Radiation Therapy. (2018) (18)
- What the diagnostic radiologist needs to know about radiation oncology. (2011) (17)
- Analysis of Long-Term 4-Dimensional Computed Tomography Regional Ventilation After Radiation Therapy. (2015) (17)
- A Quantitative CT Imaging Signature Predicts Survival and Complements Established Prognosticators in Stage I Non-Small Cell Lung Cancer. (2018) (17)
- Hypofractionated Intensity-Modulated Radiotherapy for Patients With Non-Small-Cell Lung Cancer. (2016) (15)
- Vagal and recurrent laryngeal neuropathy following stereotactic ablative radiation therapy in the chest. (2014) (14)
- A Phase I/II Dose-Escalation Trial of 3-Fraction Stereotactic Radiosurgery (SRS) for Large Resection Cavities of Brain Metastases (2015) (14)
- Short Diagnosis-to-Treatment Interval Is Associated With Higher Circulating Tumor DNA Levels in Diffuse Large B-Cell Lymphoma (2021) (14)
- Long-Term Survival of a Patient With Non-Small-Cell Lung Cancer Harboring a V600E Mutation in the BRAF Oncogene. (2016) (13)
- A method for detecting and correcting feature misidentification on expression microarrays (2004) (13)
- Profiling of Circulating Tumor DNA for Noninvasive Disease Detection, Risk Stratification, and MRD Monitoring in Patients with CNS Lymphoma (2021) (13)
- Yap1 promotes the survival and self-renewal of breast tumor initiating cells via inhibiting Smad3 signaling (2015) (13)
- Circulating DNA for Molecular Response Prediction, Characterization of Resistance Mechanisms and Quantification of CAR T-Cells during Axicabtagene Ciloleucel Therapy (2019) (12)
- SABR-COMET: harbinger of a new cancer treatment paradigm (2019) (12)
- Clinical implications of KEAP1-NFE2L2 mutations in non-small cell lung cancer. (2020) (12)
- Prognostic value and molecular correlates of a CT image-based quantitative pleural contact index in early stage NSCLC (2018) (12)
- Detection and Diagnostic Utilization of Cellular and Cell-Free Tumor DNA. (2020) (11)
- Noninvasive Genotyping and Assessment of Treatment Response in Diffuse Large B Cell Lymphoma (2015) (11)
- FLT-PET-CT for the Detection of Disease Recurrence After Stereotactic Ablative Radiotherapy or Hyperfractionation for Thoracic Malignancy: A Prospective Pilot Study (2019) (10)
- OC-0505: Interim results of a randomized trial of observation versus SABR for oligometastatic prostate cancer (2018) (10)
- 3D Riesz-wavelet based Covariance descriptors for texture classification of lung nodule tissue in CT (2015) (10)
- Dynamic Noninvasive Genomic Monitoring for Outcome Prediction in Diffuse Large B-Cell Lymphoma (2015) (10)
- Outcomes of Modestly Hypofractionated Radiation for Lung Tumors: Pre- and Mid-Treatment Positron Emission Tomography-Computed Tomography Metrics as Prognostic Factors. (2015) (10)
- Development and Validation of Biopsy-Free Genotyping for Molecular Subtyping of Diffuse Large B-Cell Lymphoma (2016) (10)
- Determinants of Circulating Tumor DNA Levels across Lymphoma Histologic Subtypes (2017) (9)
- The impact of audiovisual biofeedback on 4D functional and anatomic imaging: Results of a lung cancer pilot study. (2016) (9)
- A population-based comparative effectiveness study of chemoradiation regimens and sequences in stage III non-small cell lung cancer. (2017) (9)
- Neural Stem Cells and Gene Therapy : Prospects for Repairing the Injured Spinal Cord (2000) (9)
- Comprehensive Analysis of the Unfolded Protein Response in Breast Cancer Subtypes. (2017) (9)
- Molecular and Immunologic Signatures are Related to Clinical Benefit from Treatment with Vocimagene Amiretrorepvec (Toca 511) and 5-Fluorocytosine (Toca FC) in Patients with Glioma (2020) (9)
- A 3-D Riesz-Covariance Texture Model for Prediction of Nodule Recurrence in Lung CT. (2016) (8)
- Feasibility and Potential Utility of Multicomponent Exhaled Breath Analysis for Predicting Development of Radiation Pneumonitis After Stereotactic Ablative Radiotherapy (2014) (8)
- Circulating Tumor DNA Analysis during Radiation Therapy for Localized Lung Cancer Predicts Treatment Outcome (2017) (8)
- GFPT 2-expressing cancer-associated fibroblasts mediate metabolic reprogramming in human lung adenocarcinoma (2018) (8)
- Molecular determinants of radiation response in non-small cell lung cancer. (2015) (8)
- Highly aneuploid non-small cell lung cancer shows enhanced responsiveness to concurrent radiation and immune checkpoint blockade. (2022) (8)
- Towards Non-Invasive Classification of DLBCL Genetic Subtypes By Ctdna Profiling (2019) (8)
- Immunotherapy in small cell lung cancer (2016) (8)
- Noninvasive Detection of Ibrutinib Resistance in Non-Hodgkin Lymphoma Using Cell-Free DNA (2016) (8)
- A Comprehensive Circulating Tumor DNA Assay for Detection of Translocation and Copy-Number Changes in Pediatric Sarcomas (2021) (7)
- Lung volume reduction after stereotactic ablative radiation therapy of lung tumors: potential application to emphysema. (2013) (6)
- Prediction of therapeutic outcomes in DLBCL from circulating tumor DNA dynamics. (2016) (6)
- Noninvasive pulmonary nodule elastometry by CT and deformable image registration. (2015) (6)
- Determinants of resistance to engineered T cell therapies targeting CD19 in large B cell lymphomas. (2022) (6)
- Predictors of Respiratory Decline Following Stereotactic Ablative Radiotherapy to Multiple Lung Tumors. (2019) (6)
- Analysis of circulating tumor DNA in localized lung cancer for detection of molecular residual disease and personalization of adjuvant strategies. (2017) (6)
- MATRIX INDUCTION FOLLOWED BY AUTOLOGOUS STEM CELL TRANSPLANT OR WHOLE‐BRAIN IRRADIATION IN PRIMARY CNS LYMPHOMA. 7‐YEAR RESULTS OF THE IELSG32 RANDOMIZED TRIAL (2021) (5)
- Circulating Tumor DNA Is a Reliable Measure of Tumor Burden at Diagnosis of Diffuse Large B Cell Lymphoma: An International Reproducibility Study (2017) (5)
- Circulating Tumor DNA Concentrations Reflect Metabolic Tumor Volume in NSCLC (2014) (5)
- Inter- and intra-patient heterogeneity of resistance mechanisms to the mutant EGFR selective inhibitor rociletinib. (2016) (5)
- Sinoatrial node toxicity after stereotactic ablative radiation therapy to lung tumors. (2017) (5)
- Radiotherapy in combination with CD47 blockade elicits a macrophage-mediated abscopal effect (2022) (5)
- Phased Variant Enrichment for Enhanced Minimal Residual Disease Detection from Cell-Free DNA (2019) (5)
- Noninvasive detection of clinically relevant copy number alterations in diffuse large B-cell lymphoma. (2017) (5)
- Noninvasive and Ultrasensitive Quantitation of Circulating Tumor DNA by Hybrid Capture and Deep Sequencing (2013) (5)
- Genomic Profiling of Bronchoalveolar Lavage Fluid in Lung Cancer (2019) (4)
- A review of immunotherapy for stage 3 and metastatic NSCLC & the rationale for the ECOG-ACRIN EA5181 study. (2021) (4)
- Comparison of Genomic Driver Oncogenes in Vietnamese Patients With Non–Small-Cell Lung Cancer in the United States and Vietnam (2018) (4)
- Stem Cells, Cell Differentiation, and Cancer (2020) (4)
- Noninvasive monitoring of cellular versus acellular tumor DNA from immunoglobulin genes for DLBCL. (2014) (4)
- Analysis of Circulating Tumor Cells in Early Stage Non-Small Cell Lung Cancer Patients Treated With Stereotactic Ablative Radiation Therapy (2013) (4)
- The effect of arm position on the dosimetry of thoracic stereotactic ablative radiation therapy using volumetric modulated arc therapy. (2014) (4)
- Utility Of Non-Invasive Monitoring Of Circulating Tumor DNA At Diagnosis, Interim Therapy, and Relapse Of DLBCL Using High-Throughput Sequencing Of Immunoglobulin Genes (2013) (4)
- An Atlas of Clinically-Distinct Tumor Cellular Ecosystems in Diffuse Large B Cell Lymphoma (2019) (4)
- Local Recurrence Outcomes of Colorectal Cancer Oligometastases Treated With Stereotactic Ablative Radiotherapy (2021) (4)
- Integrated digital error suppression for noninvasive detection of circulating tumor DNA in NSCLC. (2016) (4)
- Comparison of Circulating Tumor DNA Recovery from Plasma and Serum (2017) (4)
- Clinically-relevant cell type cross-talk identified from a human lung tumor microenvironment interactome (2019) (4)
- SU-D-17A-04: The Impact of Audiovisual Biofeedback On Image Quality During 4D Functional and Anatomic Imaging: Results of a Prospective Clinical Trial. (2014) (3)
- Overcoming Radioresistance of Lung Cancer Stem Cells (2014) (3)
- Circulating tumor DNA analysis for outcome prediction in localized esophageal cancer. (2017) (3)
- Targeted Treatment of Multiple Primary Lung Cancers Harboring Distinct EGFR or RET Alterations: A Case Report. (2020) (3)
- Stereotactic Ablative Radiotherapy for Central and Ultra-Central Lung Tumors. (2019) (3)
- Invasive nodal evaluation prior to stereotactic ablative radiation for non-small cell lung cancer. (2018) (3)
- NFE2L2 mutations enhance radioresistance in head and neck cancer by modulating intratumoral myeloid cells. (2023) (3)
- Time course and predictive factors for lung volume reduction following stereotactic ablative radiotherapy (SABR) of lung tumors (2016) (3)
- Distinct Chromatin Accessibility Profiles of Lymphoma Subtypes Revealed By Targeted Cell Free DNA Profiling (2018) (3)
- Influence of Tumor Hypoxia on Stereotactic Ablative Radiotherapy (SABR): Response to Drs. Meyer and Timmerman (2011) (3)
- Interim Circulating Tumor DNA As a Prognostic Biomarker in the Setting of Interim PET-Based Adaptive Therapy for DLBCL (2019) (3)
- Analysis of Circulating Tumor DNA Kinetics during Stereotactic Ablative Radiation Therapy for Non-Small Cell Lung Cancer (2018) (3)
- CAPP-Seq Circulating Tumor DNA Analysis for Early Detection of Tumor Progression After Definitive Radiation Therapy for Lung Cancer. (2016) (3)
- Anatomic optimization of lung tumor stereotactic ablative radiation therapy. (2015) (3)
- A Review of Immunotherapy for Stage III and Metastatic Non-Small Cell Lung Cancer and the Rationale for the ECOG-ACRIN EA5181 Study (2021) (3)
- Recurrent Crebbp Mutations in Follicular Lymphoma Appear Localized to the Committed B-Cell Lineage (2020) (3)
- Response Letter: Radiation therapy for COVID-19 pneumopathy (2020) (3)
- Evolution and clinical impact of genetic epistasis within EGFR-mutant lung cancers (2017) (3)
- Pre-treatment circulating tumor DNA as a biomarker for disease burden in diffuse large B cell lymphoma (DLBCL). (2015) (2)
- Reply to J. Wang et al. (2019) (2)
- Genome-scale Identification of Secreted and Membrane-associated Tumor Markers (2005) (2)
- Case Series of MET Exon 14 Skipping Mutation-positive Non-Small Cell Lung Cancers and Response to Crizotinib. (2017) (2)
- Analytical validation of digital cytometry (iSort) for leukocyte enumeration using stored blood. (2020) (2)
- Noninvasive Genotyping and Monitoring of Classical Hodgkin Lymphoma (2018) (2)
- Increases in Serial Pretreatment 18F-FDG PET-CT Metrics Predict Survival in Early Stage Non-Small Cell Lung Cancer Treated With Stereotactic Ablative Radiation Therapy (2018) (2)
- NONINVASIVE DETECTION, CLASSIFICATION, AND RISK STRATIFICATION OF PRIMARY CNS LYMPHOMAS BY CTDNA PROFILING (2021) (2)
- DETERMINANTS OF RESISTANCE TO ENGINEERED T‐CELL THERAPIES TARGETING CD19 IN LYMPHOMA (2021) (2)
- Analysis of circulating tumor DNA in the phase 2 BTCRC LUN 16-081 trial of consolidation nivolumab with or without ipilimumab after chemoradiation in stage III non–small cell lung cancer. (2022) (2)
- Analysis of Migration of Implanted Markers for Image-Guided Lung Tumor Stereotactic Ablative Radiotherapy (2011) (2)
- Pulmonary function after lung tumor stereotactic ablative radiotherapy depends on regional ventilation within irradiated lung. (2017) (2)
- Phased variants improve DLBCL minimal residual disease detection at the end of therapy. (2021) (2)
- Abstract PO-069: Circulating tumor DNA kinetics to identify genomic predictors of rapid response to chemoradiation in non-small cell lung cancer (2021) (2)
- Circulating Tumor DNA Quantitation for Early Response Assessment of Immune Checkpoint Inhibitors for Lung Cancer (2017) (2)
- Line-Enhanced Deformable Registration of Pulmonary Computed Tomography Images Before and After Radiation Therapy With Radiation-Induced Fibrosis (2018) (2)
- Profiling T-Cell Receptor Diversity and Dynamics during Lymphoma Immunotherapy Using Cell-Free DNA (cfDNA) (2020) (2)
- Determining cell type abundance and expression from bulk tissues with digital cytometry (2019) (2)
- Distinct early response dynamics of circulating tumor DNA and circulating tumor cells during therapy of B-cell NHL. (2015) (2)
- A Feasibility Study of Single-inhalation, Single-energy Xenon-enhanced CT for High-resolution Imaging of Regional Lung Ventilation in Humans. (2019) (2)
- Predictive Radiation Oncology – A New NCI–DOE Scientific Space and Community (2022) (2)
- Development of a Dynamic Model for Personalized Risk Assessment in Large B-Cell Lymphoma (2017) (2)
- Noninvasive identification of emergent mutations following cytotoxic therapy for lung cancer. (2021) (1)
- ST002. Analysis of Urinary Cell-free DNA for Early Detection and Surveillance of Bladder Cancer (2019) (1)
- Esophagitis in Patients Treated with Thoracic Stereotactic Ablative Radiation Therapy (SABR) to Tumors within 2 cm of the Esophagus (2018) (1)
- Hierarchy in Somatic Mutations Detected in Circulating and Tissue-Resident Follicular Lymphoma Precursors before Clinical Diagnosis (2017) (1)
- Pulmonary Hemorrhage in Patients Treated with Thoracic Stereotactic Ablative Radiotherapy and Anti-Angiogenic Agents. (2023) (1)
- The Optimal Use of Radiotherapy in Small Cell Lung Cancer (2013) (1)
- Investigating Mechanisms of Cancer Stem Cell Radioresistance (2008) (1)
- Clinical Impact of Somatic Copy Number Alterations in Circulating Tumor DNA from Diverse Lymphoma Subtypes (2017) (1)
- Analytical validation of iSort digital cytometry for leukocyte enumeration in clinical tumor specimens. (2020) (1)
- Tumor-Confirmed Follicular Lymphoma Mutations Are Detectable in Peripheral Blood Years Prior to Clinical Diagnosis (2021) (1)
- DNA MICROARRAYS AS "MICROSCOPES" FOR WATCHING A GENOME IN ACTION (1998) (1)
- Circulating Tumor DNA Profiling for Detection, Risk Stratification, and Classification of Brain Lymphomas (2022) (1)
- Analyzing the Sensitivity of Breast Cancer Stem Cells to Ionizing Radiation and Chemotherapy (2007) (1)
- Isolation of membrane-bound polysomal RNA (2001) (1)
- Absence of Evidence Implicating Hematopoietic Stem Cells As Common Progenitors for DLBCL Mutations (2016) (1)
- Mechanisms and Markers of Clinical Radioresistance (2020) (1)
- Influence of Dose and Fractionation on Radiologic Lung Fibrosis after Stereotactic Ablative Radiotherapy (SABR) (2019) (1)
- Noninvasive Detection of BCL2, BCL6, and MYC Translocations in Diffuse Large B-Cell Lymphoma (2016) (1)
- Distinct Molecular Subtypes of Classic Hodgkin Lymphoma Identified By Comprehensive Noninvasive Profiling (2022) (1)
- Characterization of Metastatic Non-Small Cell Lung Cancer and Oligometastatic Incidence in an Era of Changing Treatment Paradigms. (2022) (1)
- Early Assessment of Chemotherapy Response in Advanced Non-Small Cell Lung Cancer with Circulating Tumor DNA (2022) (1)
- Abstract ES5-2: Circulating tumor DNA analysis for liquid biopsies: Current status and future opportunities (2016) (1)
- Factors Contributing to the Use of Intensity Modulated Versus 3D Conformal Radiation Therapy for Stage III Non-Small Cell Lung Cancer: A SEER-Medicare Study (2014) (1)
- Tumor and Stem Cell Biology Neuregulin Autocrine Signaling Promotes Self-Renewal of Breast Tumor-Initiating Cells by Triggering HER 2 / HER 3 Activation (2013) (1)
- SU-E-J-130: Impact of Audiovisual Biofeedback Respiratory Training On 4D-CT Image Quality (2013) (1)
- Circulating Tumor DNA Changes During Chemoradiation for Lung Cancer Predict Patient Outcomes (2019) (1)
- Noninvasive Pulmonary Nodule Elastometry by CT and Deformable Image Registration (2014) (1)
- Pretreatment Circulating Tumor DNA for Risk Stratification of Locally Advanced Esophageal Cancer Treated With Chemoradiation and Surgery (2017) (1)
- Genomic feature selection by coverage design optimization (2018) (1)
- Effectiveness of Radiation Therapy for Low- to Intermediate-Grade Neuroendocrine Tumors (2016) (1)
- Clinical Implementation of Intrafraction CBCT Imaging During Lung Tumor SABR (2013) (1)
- Early detection of post-transplant lymphoproliferative disorder using circulating tumor DNA. (2018) (1)
- Leveraging phased variants for personalized minimal residual disease detection in localized non-small cell lung cancer. (2021) (1)
- A Non-Invasive Approach for Molecular Characterization of Glioblastoma Multiforme: Magnetic Resonance Imaging Correlation with cDNA Microarray Expression Profiles (2004) (1)
- Analysis of Circulating Tumor DNA in Esophageal Carcinoma Patients Treated With Chemoradiation Therapy (2015) (1)
- MO01.01 Durvalumab for Patients with Stage III EGFR-Mutated Non-Small Cell Lung Cancer Receiving Definitive Chemoradiotherapy (2021) (1)
- Ultrasensitive Detection of Circulating Tumor DNA in Non-Small Cell Lung Cancer by Deep Sequencing (2014) (1)
- Noninvasive molecular subtyping and risk stratification of DLBCL. (2016) (1)
- ctDNA analysis for personalization of consolidation immunotherapy in localized non-small cell lung cancer. (2019) (1)
- Practical workflow for rapid prototyping of radiation therapy positioning devices. (2017) (1)
- Deep Learning Based Identification and Segmentation of Lung Tumors on Computed Tomography Images. (2021) (1)
- 18F-EF5 PET-based Imageable Hypoxia Predicts Local Recurrence in Tumors Treated with Highly Conformal Radiation Therapy (2018) (1)
- A mid-chemoradiation dynamic risk model integrating tumor features and ctDNA analysis for lung cancer outcome prediction. (2020) (1)
- Early ctDNA response assessment for prediction of platinum sensitivity in small cell lung cancer. (2020) (1)
- (P084) Stereotactic Ablative Radiotherapy for Stage I Non-Small-Cell Lung Cancer Tumors Greater Than 5 cm (2017) (0)
- Isolated Nodal Recurrence After Definitive Stereotactic Ablative Radiotherapy for Non-Small Cell Lung Cancer. (2022) (0)
- Ray-trace Calculation Significantly Overestimates Dose Compared To Monte Carlo Calculation In CyberKnife Stereotactic Ablative Radiotherapy Of Lung Tumors (2011) (0)
- Abstract 1557: Landscape of tumor cell states and cellular ecosystems in diffuse large B cell lymphoma (2020) (0)
- Real-world risk of brain metastases in stage III non-small cell lung cancer in the era of PET and MRI staging (2023) (0)
- Abstract 4403: FDG uptake in human lung adenocarcinoma associated with invasion through the hexosamine biosynthesis pathway (2017) (0)
- Abstract 1045: RePhyNER: Overcoming limitations of access to matched germline for serial liquid biopsy applications (2023) (0)
- A method for extracting sets of genes related to Magnetic Resonance Imaging (MRI) features significantly enriched for known biological function (2005) (0)
- Abstract A05: Circulating tumor DNA levels correlate with response to treatment in LMS patients (2018) (0)
- Induction EGFR tyrosine kinase inhibitors prior to definitive chemoradiotherapy in unresectable stage III EGFR-mutated non-small cell lung cancer. (2022) (0)
- MA 13.01 Clinical and Pathological Variables Influencing Noninvasive Detection of Early Stage Lung Cancer Using Circulating Tumor DNA (2017) (0)
- Improving The Prognostic Value Of FDG-PET For NSCLC Patients Treated With SABR Using Advanced Computational Modeling (2014) (0)
- Validation of Image-Based Biomarkers for Analyzing Long-term Pulmonary Toxicity After Radiation Therapy (2013) (0)
- Safety and Efficacy of Stereotactic Ablative Radiotherapy (SABR) to Multiple (3 or More) Lung Tumors (2017) (0)
- Changes in FDG-PET/CT Parameters on Serial Pre-radiotherapy Scans Predict Disease Progression and Survival in Patients with Non-small Cell Lung Cancer (2011) (0)
- Definitive Radiotherapy for New Primary Tumors in the Lung: The Benefit of the Doubt (2010) (0)
- Preradiation Therapy Metabolic Tumor Growth Rate Predicts Survival and Progression in Patients With Non-Small Cell Lung Cancer (2015) (0)
- Imaging Features Associated With Disease Progression After Stereotactic Ablative Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer: A Multi-Institutional Pooled Analysis (2016) (0)
- Comparison of Circulating Tumor DNA Analysis and Surveillance Imaging After Treatment for Localized Lung Cancer (2017) (0)
- Tumor Microenvironment Determinants of Immunotherapy Response Identified By Integrated Host & Viral Analysis of Post-Transplant Lymphoproliferative Disorders (2022) (0)
- PET/CT in lung cancer Mid-radiotherapy PET/CT for prognostication and detection of early progression in patients with stage III non-small cell lung cancer Radiotherapy and Oncology (2018) (0)
- A FUNCTIONAL INVESTIGATION OF THE FREQUENTLY MUTATED SPLICING FACTOR U2AF1 IN NON-SMALL CELL LUNG CANCER (2014) (0)
- Cancer Stem Cells and Tumor Radioresistance (2015) (0)
- Symptomatic Cardiac Events in Patients with Lung Tumors Near The Heart Treated with Stereotactic Ablative Radiotherapy (SABR): A Single Institution Experience (2019) (0)
- Abstract 3375: Ultrasensitive ctDNA minimal residual disease monitoring in early NSCLC with PhasED-Seq (2023) (0)
- Abstract C29: Development of a circulating tumor DNA assay in pancreas cancer (2019) (0)
- Cell-free DNA as a Biomarker of Residual Disease Following Radiation Therapy for Non-small Cell Lung Cancer (2012) (0)
- Durable Response and Improved CD8 T Cell Plasticity in Lung Cancer Patients After PD1 Blockade and JAK Inhibition (2022) (0)
- Viral cfDNA Profiling Reveals Distinct EBV Subtypes and Stratifies Risk in Hodgkin Lymphomas (2022) (0)
- Molecular Profiling of Oligometastases and Artificial Intelligence-based Model for Predicting Treatment Outcome in Advance Prostate Cancer (2019) (0)
- Volume Doubling Times and Outcomes in Stereotactic Ablative Radiotherapy of Early-stage Non-small Cell Lung Cancer (2011) (0)
- Predicting per-lesion local recurrence in locally advanced non-small cell lung cancer following definitive radiation therapy using pre- and mid-treatment metabolic tumor volume (2020) (0)
- Regional Failure After Stereotactic Ablative Radiation Therapy for Early-Stage Lung Cancer (2015) (0)
- Vertebral Fractures After Stereotactic Ablative Radiation Therapy of Lung Tumors (2014) (0)
- Identification of Conserved Gene Expression Programs in Epithelial Cancer Stem Cells (2009) (0)
- Role of Surveillance Imaging Versus Symptoms and Signs in Detection of Recurrence of Non-Small Cell Lung Cancer After Curative Intent Therapy. (2016) (0)
- Impact of Optimally-Gated PET on Tumor Localization and Quantification (2014) (0)
- Circulating Tumor DNA as a Biomarker for Pancreatic Adenocarcinoma (2014) (0)
- Abstract 3329: A let-7 signaling pathway targets metastatic genes enriched in tumor initiating cells (2012) (0)
- S012) Circulating Tumor DNA Detects Residual Disease and Anticipates Tumor Progression Earlier Than CT Imaging (2017) (0)
- Inferring gene expression from cell-free DNA fragmentation profiles (2022) (0)
- Acute and Late Esophageal Toxicity Following Stereotactic Ablative Radiotherapy to Thoracic Tumors near or Abutting the Esophagus. (2021) (0)
- Ultrasensitive MRD Profiling Predicts Outcomes in DLBCL after Frontline Therapy with Tafasitamab in Combination with Lenalidomide and R-CHOP (2022) (0)
- Abstract 3443: Atlas of clinically-distinct cell states and cellular ecosystems across human solid tumors (2020) (0)
- Lung Cancer Stem Cells and Resistance to Radiotherapy (2014) (0)
- Increased Rates of Pneumonitis in Patients Receiving Stereotactic Ablative Radiation Therapy for Central Versus Peripheral Lung Tumors : Treatment Toxicity (2014) (0)
- The Effect of Arm Position on the Dosimetry of Thoracic Stereotactic Ablative Radiation Therapy (2013) (0)
- Higher Rates of Severe Infection and Persistent Cytopenias in Long-Term CAR19 Responders Than after Autologous HCT: A Single Institution Study of 139 Subjects (2022) (0)
- 788 Evidence for an Evolutionarily-Conserved Mechanism Regulating Stem and Progenitor Cell Numbers in the Regenerative Response to Ulcerative Colitis (2010) (0)
- 72 – Cancer Stem Cell Biology and Its Role in Radiotherapy (2010) (0)
- Deep Sequencing of Viral Cell-Free DNA for Noninvasive Detection of Immunosuppression-Related Lymphoid Malignancies (2019) (0)
- Vesselness-Based Deformable Registration Algorithms Can Reduce Landmark Errors in the Registration of Pulmonary Computed Tomography Images Before and After Radiation Therapy (2016) (0)
- Neurotrophic factor promotes stem cell involved salivary gland regeneration post radiotherapy. (2015) (0)
- (OA02) Circulating Tumor DNA Quantitation for Early Response Assessment of Immune Checkpoint Inhibitors for Metastatic Non-Small Cell Lung Cancer (2018) (0)
- Stereotactic Ablative Radiotherapy for Previously Irradiated Lung Tumors (2011) (0)
- Short Diagnosis-to-Treatment Interval Is Associated with Higher Levels of Circulating Tumor DNA in Aggressive B-Cell Non-Hodgkin Lymphoma (2019) (0)
- Four-Dimensional Computed Tomography Pulmonary Nodule Elastometry as a Predictor of Regional Recurrence Following Stereotactic Ablative Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer (2016) (0)
- Abstract PO-066: Relationship between KEAP1/NFE2L2 pathway activation and radiation resistance in oral cavity cancer (2021) (0)
- In Reply to Song et al. (2011) (0)
- Post-transplant head and neck cancers: A prospective analysis of clinical factors for risk stratification. (2018) (0)
- Detection of Recurrence After Thoracic Stereotactic Ablative Radiotherapy Using FDG-PET-CT. (2022) (0)
- In Reply to Drs. Koch and Evans (2011) (0)
- Impact of Audiovisual Biofeedback on 4D PET Image Quality (2011) (0)
- Outcomes of Oligometastatic Colorectal Cancer treated with Stereotactic Ablative Radiotherapy (2019) (0)
- Monitoring response to treatment in leiomyosarcoma patients using circulating tumor DNA (2016) (0)
- Noninvasive Pulmonary Nodule Elastometry by CT and Deformable Image Registration: Diagnosis/Staging (2014) (0)
- Elucidation of distinct mutational patterns between diffuse large B cell lymphoma subtypes utilizing circulating tumor DNA. (2017) (0)
- Time course and predictive factors for lung volume reduction following stereotactic ablative radiotherapy (SABR) of lung tumors (2015) (0)
- PSY1-4Deep sequencing of circulating tumor DNA for personalized cancer detection and monitoring (2015) (0)
- Noninvasive Cancer Classification Using Diverse Genomic Features in Circulating Tumor DNA (2016) (0)
- Pre-Treatment Lung FDG-PET Uptake is Correlated with Radiologic Lung Fibrosis after Stereotactic Ablative Radiotherapy (SABR) (2020) (0)
- Patterns of Care in Patients With Isolated Nodal Recurrence After Definitive Stereotactic Ablative Radiotherapy for Non-Small Cell Lung Cancer. (2021) (0)
- From gene expression to the bedside: A high-throughput approach for identifying serum diagnostic markers and immunotherapy targets in human malignancies using DNA microarrays (2001) (0)
- Endothelial deletion of Ino80 disrupts coronary angiogenesis and causes congenital heart disease (2018) (0)
- Abstract 3388: Chromatin accessibility patterns in cell-free DNA reveal tumor heterogeneity (2020) (0)
- KEAP1/NFE2L2 mutations to predict local recurrence after radiotherapy but not surgery in localized non-small cell lung cancer. (2020) (0)
- Improved Outcomes in Stage I NSCLC Patients Treated in the Stereotactic Ablative Radiation Therapy Era: A Population-based Analysis (2012) (0)
- Abstract B49: Quantitating circulating tumor DNA in translocation-positive sarcoma patients using CAPP-Seq (2018) (0)
- Pulmonary Hemorrhage in Patients Treated With Thoracic Stereotactic Ablative Radiotherapy and Anti-Angiogenic Agents. (2021) (0)
- Tracing founder mutations in circulating and tissue-resident follicular lymphoma precursors. (2023) (0)
- Temporal Change in Quantitative Positron Emission Tomography Metrics Predicts Recurrence in Early-Stage Lung Cancer Patients Treated With Stereotactic Ablative Radiation Therapy (2016) (0)
- A Review of Concurrent Chemo/Radiation, Immunotherapy, Radiation Planning, and Biomarkers for Locally Advanced Non-small Cell Lung Cancer and Their Role in the Development of ECOG-ACRIN EA5181. (2022) (0)
- TU-AB-201-06: Evaluation of Electromagnetically Guided High- Dose Rate Brachytherapy for Ablative Treatment of Lung Metastases (2015) (0)
- (OA41) 18F-EF5 Pet-Based Imageable Hypoxia Predicts for Local Control in Tumors Treated With Conformal Radiotherapy (2018) (0)
- Poster ViewingOutcomes of Moderately Hypofractionated Intensity-Modulated Thoracic Radiotherapy with Concurrent Chemotherapy for Treatment of Non–Small Cell Lung Cancer (2017) (0)
- The New Atlantis and the Frontiers of Medicine THE A Modern-Day (2000) (0)
- Investigating Differential Gene Expression in Anatomical Compartments of the Human Eye Using cDNA Microarrays (2004) (0)
- Noninvasive and ultrasensitive quantitation of circulating tumor DNA by hybrid capture and deep sequencing. (2014) (0)
- Abstract PO-059: Investigating gene expression profiles associated with clinical radiation resistance in KEAP1/NFE2L2 wildtype lung cancer (2021) (0)
- A human lung tumor microenvironment interactome identifies clinically relevant cell-type cross-talk (2020) (0)
- Impact of Facility Treatment Volume on Stereotactic Ablative Radiotherapy (SABR) Outcomes in Early-Stage Non-Small Cell Lung Cancer (NSCLC). (2021) (0)
- Lymphoma Virome Dynamics Revealed By Cell-Free DNA Sequencing (2018) (0)
- Radiologic Quantification and Predictors of Lung Fibrosis after Stereotactic Ablative Radiation Therapy(SABR) (2018) (0)
- Regional Ventilation Predicts Change in Pulmonary Function After Stereotactic Ablative Radiation Therapy of Lung Tumors (2016) (0)
- Determining the Cellular Location of Macula–Enriched Genes Identified By Cdna Microarrays (2005) (0)
- PS01.67: Case Series of MET Exon 14 Skipping Mutation‐Positive Non–Small Cell Lung Cancers and Response to Crizotinib: Topic: Medical Oncology (2016) (0)
- Data normalization considerations for digital tumor dissection (2017) (0)
- A Phase II Trial of Individualized Stereotactic Ablative Radiotherapy for Lung Tumors (iSABR). (2021) (0)
- Intratumor Partitioning of Serial Computed Tomography and FDG Positron Emission Tomography Images Identifies High-Risk Tumor Subregions and Predicts Patterns of Failure in Non-Small Cell Lung Cancer After Radiation Therapy (2016) (0)
- Acceptable Toxicity Is Observed Following Retreatment of Thoracic Malignancies: Dose Volume Toxicity Data for Repeat Radiation Therapy (2015) (0)
- MA17.07 Circulating Tumor DNA Detects Minimal Residual Disease and Predicts Outcome in Localized Lung Cancer (2017) (0)
- Parametric Response Mapping as an Imaging Biomarker for Regional Ventilation in Stereotactic Ablative Radiotherapy (2020) (0)
- Abstract LB-219: Higher levels of mast cells associate with favorable outcomes in non-small cell lung cancer and correlate with lower malignant cell proliferation (2017) (0)
- Integrating genomic features for non-invasive early lung cancer detection (2020) (0)
- Abstract PR01: ctDNA shedding dynamics dictate early lung cancer detection potential (2020) (0)
- Acute Changes in Composition of Exhaled Breath Predict Radiation Pneumonitis Following Stereotactic Ablative Radiation Therapy (2012) (0)
- Abstract 2536: Mutational landscape of the bronchial epithelium of individuals at high risk for lung cancer (2021) (0)
- Predicting per-lesion local recurrence in locally advanced non-small cell lung cancer following definitive radiation therapy using pre- and mid-treatment metabolic tumor volume (2020) (0)
- Investigating the Impact of Coronary Artery Dosimetry on Major Adverse Cardiac Events after Thoracic Radiation Therapy (2022) (0)
- STK11 Inactivation Predicts Rapid Recurrence in Inoperable Early-Stage Non-Small-Cell Lung Cancer. (2023) (0)
- Feasibility of Pulmonary Interstitial Lymphography-guided Targeting in Stereotactic Ablative Radiation Therapy of Lung Tumors (2012) (0)
- Prognostic Metrics on Serial PET for Lung Tumors Treated With Hypofractionated Radiation (2013) (0)
- Mechanisms of Radioresistance in Cancer Stem Cells (2011) (0)
- Sinoatrial node dysfunction after stereotactic ablative radiation therapy in the chest. (2017) (0)
- Deep sequencing of circulating tumor DNA for personalized lung cancer detection and radiotherapy response monitoring (2016) (0)
- Novel Imaging Biomarkers in Stage I Non-Small Cell Lung Cancer Treated With Stereotactic Ablative Radiation Therapy (2013) (0)
- Oral Scientific SessionsValidation of Temporal Change in Quantitative PET Metrics as Predictors of Recurrence in Early Stage Lung Cancer Patients Treated With SABR (2017) (0)
- Abstract 864: Increased rates of radiation pneumonitis in patients receiving stereotactic ablative radiotherapy for central versus peripheral lung tumors (2014) (0)
- 31 : Neuroimaging Characteristics Reflect Tumor Gene Expression Signatures and Predict Survival in Glioblastoma Multiforme (2006) (0)
- CLONAL HEMATOPOIESIS IS ASSOCIATED WITH INFERIOR PROGNOSIS IN NEWLY DIAGNOSED DIFFUSE LARGE B‐CELL LYMPHOMA PATIENTS (2021) (0)
- First in Human High-Resolution Imaging of Regional Lung Function by Single Energy Xenon CT Compared to Ventilation SPECT (2014) (0)
- Mid-radiation Therapy PET/CT for Prognostication and Detection of Early Progression in Patients With Stage III Non–small Cell Lung Cancer (2017) (0)
- Patterns of Failure After Hypofractionated Intensity Modulated Radiation Therapy for Patients With Non-Small Cell Lung Cancer. (2016) (0)
- Imaging Based Parameters Associated With Disease Progression of Early-Stage NSCLC Treated With Surgical Resection (2015) (0)
- Pulmonary Interstitial Lymphography and Patterns of Recurrence after Stereotactic Ablative Radiation Therapy(SABR) of Lung Tumors (2018) (0)
- Patterns of Care and Health Disparities for Patients With Stage I Non–small Cell Lung Cancer in the US (2017) (0)
- tumor-initiating cells by triggering HER 2 / HER 3 activation Neuregulin autocrine signaling promotes self-renewal of breast (2013) (0)
- With DNA Microarrays Examining the Living Genome in Health and Disease (2010) (0)
- Stromal Contributions to Radiation Resistance of Breast Cancer Stem Cells (2013) (0)
- Abstract 1137: Deep targeted and whole exome sequencing identifies driver mutations in the airway epithelium of individuals at high risk for lung cancer (2020) (0)
- Abstract IA25: Deep sequencing of circulating tumor DNA for personalized cancer detection and monitoring (2016) (0)
- Abstract 3374: Characterizing a new population of adult mouse submandibular gland stem cells (2012) (0)
- SU-C-110-02: Reducing 4D CT Artifacts Using Optimized Sorting Based on Anatomic Similarity (2011) (0)
- Radiogenomic Analysis of a Peritumoral CT Image Feature and Its Prognostic Value in Early Stage NSCLC (2017) (0)
- Predicting Per-Lesion Local Recurrence in Locally Advanced Lung Cancer using Metabolic Tumor Volume on Pre- and Mid-Radiation FDG-PET (2018) (0)
- Anatomic and Metabolic Predictors of Failure After Stereotactic Ablative Radiation Therapy for Non-small Cell Lung Cancer (2012) (0)
- Pretreatment FDG Uptake of Non-Target Lung Tissue is Significantly Associated With Radiation Pneumonitis Following Stereotactic Ablative Radiation Therapy (SABR) (2015) (0)
- Increased Rates of Pneumonitis in Patients Receiving Stereotactic Ablative Radiation Therapy for Central Versus Peripheral Lung Tumors (2014) (0)
- Clonal Hematopoiesis Driven By Recurrent Somatic Mutations but Not with Recurrent Copy Number Alterations Is Associated with Inferior Outcomes in DLBCL after Induction Chemotherapy, but Not CAR19 Therapy (2022) (0)
- Performance of PET in Evaluating Local Recurrence After Stereotactic Ablative Radiation Therapy for Early Lung Cancer (2013) (0)
- Specificity & Precision of Minimal Residual Disease Monitoring in DLBCL Using Ig-HTS (2022) (0)
- Cardiac Toxicities and Outcomes Following Stereotactic Ablative Radiation to Thoracic Cancers (2020) (0)
- Noninvasive Cell-of-Origin Classification of Diffuse Large B-Cell Lymphoma Using Inferred Gene Expression from Cell-Free DNA Sequencing (2021) (0)
- Abstract 848: Galectin-1 mediates radiation-related lymphopenia in non-small cell lung cancer and attenuates tumor radiation response (2014) (0)
- ctDNA Predicts Outcomes in Lung Cancer Patients Receiving Radiation Therapy (2017) (0)
- Dose of extra oxygen revs up cancer-fighting immune cells Lung and breast tumors in mice shrank with treatment , study shows (2015) (0)
- Investigating and Validating Metabolic Tumor Volume As a Prognostic Factor for Local Recurrence in Early Stage Lung Cancer (2019) (0)
- Abstract 5666: A noninvasive approach for early prediction of therapeutic benefit from immune checkpoint inhibition for lung cancer (2020) (0)
- Characterizing Metastatic Non-Small Cell Lung Cancer Presenting to an Academic Medical Center in an Era of Changing Treatment Paradigms (2022) (0)
- MRD-Negativity As a Potential Surrogate Endpoint after Frontline DLBCL Therapy: Pooled Analysis of Trials & Implications for Clinical Trial Design (2022) (0)
- Randomized phase II study of preoperative chemoradiotherapy (CRT)+/- Panitumumab (P) followed by consolidation chemotherapy (C) in potentially operable locally advanced (stage IIIa, N2+) non-small cell lung cancer (LANSCLC): Nrg oncology/RTOG 0839. (2016) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Maximilian Diehn?
Maximilian Diehn is affiliated with the following schools:
